Global Specialty Control Plasma Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 92

Published Date: 30 Jul 2021

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Specialty Control Plasma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Specialty Control Plasma size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Specialty Control Plasma market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Specialty Control Plasma market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Factor VIII Concentrate
    Factor IX Concentrate
    Immunoglobulins
    Others

Market segment by Application, can be divided into
    Hospitals
    Diagnostic Laboratories
    Clinics
    Others

Market segment by players, this report covers
    Precision BioLogic Incorporated
    Baxter BioScience
    Grifols S.A.
    Shire Plc.
    VitroPharma
    Kedrion
    China Biologic Products (Shandong Taibang)
    Biotest AG
    Sanquin
    Talecris Biotherapeutics
    SK Plasma
    CSL
    Octapharma
    Cerus

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Specialty Control Plasma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Specialty Control Plasma, with revenue, gross margin and global market share of Specialty Control Plasma from 2019 to 2021.
Chapter 3, the Specialty Control Plasma competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Specialty Control Plasma market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Specialty Control Plasma research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Specialty Control Plasma
    1.2 Classification of Specialty Control Plasma by Type
        1.2.1 Overview: Global Specialty Control Plasma Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Specialty Control Plasma Revenue Market Share by Type in 2020
        1.2.3 Factor VIII Concentrate
        1.2.4 Factor IX Concentrate
        1.2.5 Immunoglobulins
        1.2.6 Others
    1.3 Global Specialty Control Plasma Market by Application
        1.3.1 Overview: Global Specialty Control Plasma Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Diagnostic Laboratories
        1.3.4 Clinics
        1.3.5 Others
    1.4 Global Specialty Control Plasma Market Size & Forecast
    1.5 Global Specialty Control Plasma Market Size and Forecast by Region
        1.5.1 Global Specialty Control Plasma Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Specialty Control Plasma Market Size by Region, (2016-2021)
        1.5.3 North America Specialty Control Plasma Market Size and Prospect (2016-2026)
        1.5.4 Europe Specialty Control Plasma Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Specialty Control Plasma Market Size and Prospect (2016-2026)
        1.5.6 South America Specialty Control Plasma Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Specialty Control Plasma Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Specialty Control Plasma Market Drivers
        1.6.2 Specialty Control Plasma Market Restraints
        1.6.3 Specialty Control Plasma Trends Analysis

2 Company Profiles
    2.1 Precision BioLogic Incorporated
        2.1.1 Precision BioLogic Incorporated Details
        2.1.2 Precision BioLogic Incorporated Major Business
        2.1.3 Precision BioLogic Incorporated Specialty Control Plasma Product and Solutions
        2.1.4 Precision BioLogic Incorporated Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Precision BioLogic Incorporated Recent Developments and Future Plans
    2.2 Baxter BioScience
        2.2.1 Baxter BioScience Details
        2.2.2 Baxter BioScience Major Business
        2.2.3 Baxter BioScience Specialty Control Plasma Product and Solutions
        2.2.4 Baxter BioScience Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Baxter BioScience Recent Developments and Future Plans
    2.3 Grifols S.A.
        2.3.1 Grifols S.A. Details
        2.3.2 Grifols S.A. Major Business
        2.3.3 Grifols S.A. Specialty Control Plasma Product and Solutions
        2.3.4 Grifols S.A. Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Grifols S.A. Recent Developments and Future Plans
    2.4 Shire Plc.
        2.4.1 Shire Plc. Details
        2.4.2 Shire Plc. Major Business
        2.4.3 Shire Plc. Specialty Control Plasma Product and Solutions
        2.4.4 Shire Plc. Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Shire Plc. Recent Developments and Future Plans
    2.5 VitroPharma
        2.5.1 VitroPharma Details
        2.5.2 VitroPharma Major Business
        2.5.3 VitroPharma Specialty Control Plasma Product and Solutions
        2.5.4 VitroPharma Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 VitroPharma Recent Developments and Future Plans
    2.6 Kedrion
        2.6.1 Kedrion Details
        2.6.2 Kedrion Major Business
        2.6.3 Kedrion Specialty Control Plasma Product and Solutions
        2.6.4 Kedrion Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Kedrion Recent Developments and Future Plans
    2.7 China Biologic Products (Shandong Taibang)
        2.7.1 China Biologic Products (Shandong Taibang) Details
        2.7.2 China Biologic Products (Shandong Taibang) Major Business
        2.7.3 China Biologic Products (Shandong Taibang) Specialty Control Plasma Product and Solutions
        2.7.4 China Biologic Products (Shandong Taibang) Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 China Biologic Products (Shandong Taibang) Recent Developments and Future Plans
    2.8 Biotest AG
        2.8.1 Biotest AG Details
        2.8.2 Biotest AG Major Business
        2.8.3 Biotest AG Specialty Control Plasma Product and Solutions
        2.8.4 Biotest AG Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Biotest AG Recent Developments and Future Plans
    2.9 Sanquin
        2.9.1 Sanquin Details
        2.9.2 Sanquin Major Business
        2.9.3 Sanquin Specialty Control Plasma Product and Solutions
        2.9.4 Sanquin Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Sanquin Recent Developments and Future Plans
    2.10 Talecris Biotherapeutics
        2.10.1 Talecris Biotherapeutics Details
        2.10.2 Talecris Biotherapeutics Major Business
        2.10.3 Talecris Biotherapeutics Specialty Control Plasma Product and Solutions
        2.10.4 Talecris Biotherapeutics Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Talecris Biotherapeutics Recent Developments and Future Plans
    2.11 SK Plasma
        2.11.1 SK Plasma Details
        2.11.2 SK Plasma Major Business
        2.11.3 SK Plasma Specialty Control Plasma Product and Solutions
        2.11.4 SK Plasma Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 SK Plasma Recent Developments and Future Plans
    2.12 CSL
        2.12.1 CSL Details
        2.12.2 CSL Major Business
        2.12.3 CSL Specialty Control Plasma Product and Solutions
        2.12.4 CSL Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 CSL Recent Developments and Future Plans
    2.13 Octapharma
        2.13.1 Octapharma Details
        2.13.2 Octapharma Major Business
        2.13.3 Octapharma Specialty Control Plasma Product and Solutions
        2.13.4 Octapharma Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Octapharma Recent Developments and Future Plans
    2.14 Cerus
        2.14.1 Cerus Details
        2.14.2 Cerus Major Business
        2.14.3 Cerus Specialty Control Plasma Product and Solutions
        2.14.4 Cerus Specialty Control Plasma Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Cerus Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Specialty Control Plasma Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Specialty Control Plasma Players Market Share
        3.2.2 Top 10 Specialty Control Plasma Players Market Share
        3.2.3 Market Competition Trend
    3.3 Specialty Control Plasma Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Specialty Control Plasma Revenue and Market Share by Type (2016-2021)
    4.2 Global Specialty Control Plasma Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Specialty Control Plasma Revenue Market Share by Application (2016-2021)
    5.2 Specialty Control Plasma Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Specialty Control Plasma Revenue by Type (2016-2026)
    6.2 North America Specialty Control Plasma Revenue by Application (2016-2026)
    6.3 North America Specialty Control Plasma Market Size by Country
        6.3.1 North America Specialty Control Plasma Revenue by Country (2016-2026)
        6.3.2 United States Specialty Control Plasma Market Size and Forecast (2016-2026)
        6.3.3 Canada Specialty Control Plasma Market Size and Forecast (2016-2026)
        6.3.4 Mexico Specialty Control Plasma Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Specialty Control Plasma Revenue by Type (2016-2026)
    7.2 Europe Specialty Control Plasma Revenue by Application (2016-2026)
    7.3 Europe Specialty Control Plasma Market Size by Country
        7.3.1 Europe Specialty Control Plasma Revenue by Country (2016-2026)
        7.3.2 Germany Specialty Control Plasma Market Size and Forecast (2016-2026)
        7.3.3 France Specialty Control Plasma Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Specialty Control Plasma Market Size and Forecast (2016-2026)
        7.3.5 Russia Specialty Control Plasma Market Size and Forecast (2016-2026)
        7.3.6 Italy Specialty Control Plasma Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Specialty Control Plasma Revenue by Type (2016-2026)
    8.2 Asia-Pacific Specialty Control Plasma Revenue by Application (2016-2026)
    8.3 Asia-Pacific Specialty Control Plasma Market Size by Region
        8.3.1 Asia-Pacific Specialty Control Plasma Revenue by Region (2016-2026)
        8.3.2 China Specialty Control Plasma Market Size and Forecast (2016-2026)
        8.3.3 Japan Specialty Control Plasma Market Size and Forecast (2016-2026)
        8.3.4 South Korea Specialty Control Plasma Market Size and Forecast (2016-2026)
        8.3.5 India Specialty Control Plasma Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Specialty Control Plasma Market Size and Forecast (2016-2026)
        8.3.7 Australia Specialty Control Plasma Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Specialty Control Plasma Revenue by Type (2016-2026)
    9.2 South America Specialty Control Plasma Revenue by Application (2016-2026)
    9.3 South America Specialty Control Plasma Market Size by Country
        9.3.1 South America Specialty Control Plasma Revenue by Country (2016-2026)
        9.3.2 Brazil Specialty Control Plasma Market Size and Forecast (2016-2026)
        9.3.3 Argentina Specialty Control Plasma Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Specialty Control Plasma Revenue by Type (2016-2026)
    10.2 Middle East & Africa Specialty Control Plasma Revenue by Application (2016-2026)
    10.3 Middle East & Africa Specialty Control Plasma Market Size by Country
        10.3.1 Middle East & Africa Specialty Control Plasma Revenue by Country (2016-2026)
        10.3.2 Turkey Specialty Control Plasma Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Specialty Control Plasma Market Size and Forecast (2016-2026)
        10.3.4 UAE Specialty Control Plasma Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Specialty Control Plasma Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Specialty Control Plasma Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Specialty Control Plasma Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Specialty Control Plasma Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Specialty Control Plasma Revenue Market Share by Region (2021-2026)
    Table 6. Precision BioLogic Incorporated Corporate Information, Head Office, and Major Competitors
    Table 7. Precision BioLogic Incorporated Major Business
    Table 8. Precision BioLogic Incorporated Specialty Control Plasma Product and Solutions
    Table 9. Precision BioLogic Incorporated Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Baxter BioScience Corporate Information, Head Office, and Major Competitors
    Table 11. Baxter BioScience Major Business
    Table 12. Baxter BioScience Specialty Control Plasma Product and Solutions
    Table 13. Baxter BioScience Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Grifols S.A. Corporate Information, Head Office, and Major Competitors
    Table 15. Grifols S.A. Major Business
    Table 16. Grifols S.A. Specialty Control Plasma Product and Solutions
    Table 17. Grifols S.A. Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Shire Plc. Corporate Information, Head Office, and Major Competitors
    Table 19. Shire Plc. Major Business
    Table 20. Shire Plc. Specialty Control Plasma Product and Solutions
    Table 21. Shire Plc. Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. VitroPharma Corporate Information, Head Office, and Major Competitors
    Table 23. VitroPharma Major Business
    Table 24. VitroPharma Specialty Control Plasma Product and Solutions
    Table 25. VitroPharma Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Kedrion Corporate Information, Head Office, and Major Competitors
    Table 27. Kedrion Major Business
    Table 28. Kedrion Specialty Control Plasma Product and Solutions
    Table 29. Kedrion Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. China Biologic Products (Shandong Taibang) Corporate Information, Head Office, and Major Competitors
    Table 31. China Biologic Products (Shandong Taibang) Major Business
    Table 32. China Biologic Products (Shandong Taibang) Specialty Control Plasma Product and Solutions
    Table 33. China Biologic Products (Shandong Taibang) Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Biotest AG Corporate Information, Head Office, and Major Competitors
    Table 35. Biotest AG Major Business
    Table 36. Biotest AG Specialty Control Plasma Product and Solutions
    Table 37. Biotest AG Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Sanquin Corporate Information, Head Office, and Major Competitors
    Table 39. Sanquin Major Business
    Table 40. Sanquin Specialty Control Plasma Product and Solutions
    Table 41. Sanquin Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Talecris Biotherapeutics Corporate Information, Head Office, and Major Competitors
    Table 43. Talecris Biotherapeutics Major Business
    Table 44. Talecris Biotherapeutics Specialty Control Plasma Product and Solutions
    Table 45. Talecris Biotherapeutics Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. SK Plasma Corporate Information, Head Office, and Major Competitors
    Table 47. SK Plasma Major Business
    Table 48. SK Plasma Specialty Control Plasma Product and Solutions
    Table 49. SK Plasma Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. CSL Corporate Information, Head Office, and Major Competitors
    Table 51. CSL Major Business
    Table 52. CSL Specialty Control Plasma Product and Solutions
    Table 53. CSL Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Octapharma Corporate Information, Head Office, and Major Competitors
    Table 55. Octapharma Major Business
    Table 56. Octapharma Specialty Control Plasma Product and Solutions
    Table 57. Octapharma Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Cerus Corporate Information, Head Office, and Major Competitors
    Table 59. Cerus Major Business
    Table 60. Cerus Specialty Control Plasma Product and Solutions
    Table 61. Cerus Specialty Control Plasma Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Global Specialty Control Plasma Revenue (USD Million) by Players (2019-2021)
    Table 63. Global Specialty Control Plasma Revenue Share by Players (2019-2021)
    Table 64. Breakdown of Specialty Control Plasma by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Specialty Control Plasma Players Head Office, Products and Services Provided
    Table 66. Specialty Control Plasma Mergers & Acquisitions in the Past Five Years
    Table 67. Specialty Control Plasma New Entrants and Expansion Plans
    Table 68. Global Specialty Control Plasma Revenue (USD Million) by Type (2016-2021)
    Table 69. Global Specialty Control Plasma Revenue Share by Type (2016-2021)
    Table 70. Global Specialty Control Plasma Revenue Forecast by Type (2021-2026)
    Table 71. Global Specialty Control Plasma Revenue by Application (2016-2021)
    Table 72. Global Specialty Control Plasma Revenue Forecast by Application (2021-2026)
    Table 73. North America Specialty Control Plasma Revenue by Type (2016-2021) & (USD Million)
    Table 74. North America Specialty Control Plasma Revenue by Type (2021-2026) & (USD Million)
    Table 75. North America Specialty Control Plasma Revenue by Application (2016-2021) & (USD Million)
    Table 76. North America Specialty Control Plasma Revenue by Application (2021-2026) & (USD Million)
    Table 77. North America Specialty Control Plasma Revenue by Country (2016-2021) & (USD Million)
    Table 78. North America Specialty Control Plasma Revenue by Country (2021-2026) & (USD Million)
    Table 79. Europe Specialty Control Plasma Revenue by Type (2016-2021) & (USD Million)
    Table 80. Europe Specialty Control Plasma Revenue by Type (2021-2026) & (USD Million)
    Table 81. Europe Specialty Control Plasma Revenue by Application (2016-2021) & (USD Million)
    Table 82. Europe Specialty Control Plasma Revenue by Application (2021-2026) & (USD Million)
    Table 83. Europe Specialty Control Plasma Revenue by Country (2016-2021) & (USD Million)
    Table 84. Europe Specialty Control Plasma Revenue by Country (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Specialty Control Plasma Revenue by Type (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Specialty Control Plasma Revenue by Type (2021-2026) & (USD Million)
    Table 87. Asia-Pacific Specialty Control Plasma Revenue by Application (2016-2021) & (USD Million)
    Table 88. Asia-Pacific Specialty Control Plasma Revenue by Application (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Specialty Control Plasma Revenue by Region (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Specialty Control Plasma Revenue by Region (2021-2026) & (USD Million)
    Table 91. South America Specialty Control Plasma Revenue by Type (2016-2021) & (USD Million)
    Table 92. South America Specialty Control Plasma Revenue by Type (2021-2026) & (USD Million)
    Table 93. South America Specialty Control Plasma Revenue by Application (2016-2021) & (USD Million)
    Table 94. South America Specialty Control Plasma Revenue by Application (2021-2026) & (USD Million)
    Table 95. South America Specialty Control Plasma Revenue by Country (2016-2021) & (USD Million)
    Table 96. South America Specialty Control Plasma Revenue by Country (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Specialty Control Plasma Revenue by Type (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Specialty Control Plasma Revenue by Type (2021-2026) & (USD Million)
    Table 99. Middle East & Africa Specialty Control Plasma Revenue by Application (2016-2021) & (USD Million)
    Table 100. Middle East & Africa Specialty Control Plasma Revenue by Application (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Specialty Control Plasma Revenue by Country (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Specialty Control Plasma Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Specialty Control Plasma Picture
    Figure 2. Global Specialty Control Plasma Revenue Market Share by Type in 2020
    Figure 3. Factor VIII Concentrate
    Figure 4. Factor IX Concentrate
    Figure 5. Immunoglobulins
    Figure 6. Others
    Figure 7. Specialty Control Plasma Revenue Market Share by Application in 2020
    Figure 8. Hospitals Picture
    Figure 9. Diagnostic Laboratories Picture
    Figure 10. Clinics Picture
    Figure 11. Others Picture
    Figure 12. Global Specialty Control Plasma Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 13. Global Specialty Control Plasma Revenue and Forecast (2016-2026) & (USD Million)
    Figure 14. Global Specialty Control Plasma Revenue Market Share by Region (2016-2026)
    Figure 15. Global Specialty Control Plasma Revenue Market Share by Region in 2020
    Figure 16. North America Specialty Control Plasma Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Europe Specialty Control Plasma Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Asia-Pacific Specialty Control Plasma Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. South America Specialty Control Plasma Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Middle East and Africa Specialty Control Plasma Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. Specialty Control Plasma Market Drivers
    Figure 22. Specialty Control Plasma Market Restraints
    Figure 23. Specialty Control Plasma Market Trends
    Figure 24. Precision BioLogic Incorporated Recent Developments and Future Plans
    Figure 25. Baxter BioScience Recent Developments and Future Plans
    Figure 26. Grifols S.A. Recent Developments and Future Plans
    Figure 27. Shire Plc. Recent Developments and Future Plans
    Figure 28. VitroPharma Recent Developments and Future Plans
    Figure 29. Kedrion Recent Developments and Future Plans
    Figure 30. China Biologic Products (Shandong Taibang) Recent Developments and Future Plans
    Figure 31. Biotest AG Recent Developments and Future Plans
    Figure 32. Sanquin Recent Developments and Future Plans
    Figure 33. Talecris Biotherapeutics Recent Developments and Future Plans
    Figure 34. SK Plasma Recent Developments and Future Plans
    Figure 35. CSL Recent Developments and Future Plans
    Figure 36. Octapharma Recent Developments and Future Plans
    Figure 37. Cerus Recent Developments and Future Plans
    Figure 38. Global Specialty Control Plasma Revenue Share by Players in 2020
    Figure 39. Specialty Control Plasma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 40. Global Top 3 Players Specialty Control Plasma Revenue Market Share in 2020
    Figure 41. Global Top 10 Players Specialty Control Plasma Revenue Market Share in 2020
    Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 43. Global Specialty Control Plasma Revenue Share by Type in 2020
    Figure 44. Global Specialty Control Plasma Market Share Forecast by Type (2021-2026)
    Figure 45. Global Specialty Control Plasma Revenue Share by Application in 2020
    Figure 46. Global Specialty Control Plasma Market Share Forecast by Application (2021-2026)
    Figure 47. North America Specialty Control Plasma Sales Market Share by Type (2016-2026)
    Figure 48. North America Specialty Control Plasma Sales Market Share by Application (2016-2026)
    Figure 49. North America Specialty Control Plasma Revenue Market Share by Country (2016-2026)
    Figure 50. United States Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Canada Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Mexico Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Europe Specialty Control Plasma Sales Market Share by Type (2016-2026)
    Figure 54. Europe Specialty Control Plasma Sales Market Share by Application (2016-2026)
    Figure 55. Europe Specialty Control Plasma Revenue Market Share by Country (2016-2026)
    Figure 56. Germany Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. France Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. United Kingdom Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Russia Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Italy Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Asia-Pacific Specialty Control Plasma Sales Market Share by Type (2016-2026)
    Figure 62. Asia-Pacific Specialty Control Plasma Sales Market Share by Application (2016-2026)
    Figure 63. Asia-Pacific Specialty Control Plasma Revenue Market Share by Region (2016-2026)
    Figure 64. China Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Japan Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South Korea Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. India Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Southeast Asia Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Australia Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. South America Specialty Control Plasma Sales Market Share by Type (2016-2026)
    Figure 71. South America Specialty Control Plasma Sales Market Share by Application (2016-2026)
    Figure 72. South America Specialty Control Plasma Revenue Market Share by Country (2016-2026)
    Figure 73. Brazil Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Argentina Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Middle East and Africa Specialty Control Plasma Sales Market Share by Type (2016-2026)
    Figure 76. Middle East and Africa Specialty Control Plasma Sales Market Share by Application (2016-2026)
    Figure 77. Middle East and Africa Specialty Control Plasma Revenue Market Share by Country (2016-2026)
    Figure 78. Turkey Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Saudi Arabia Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. UAE Specialty Control Plasma Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Precision BioLogic Incorporated
Baxter BioScience
Grifols S.A.
Shire Plc.
VitroPharma
Kedrion
China Biologic Products (Shandong Taibang)
Biotest AG
Sanquin
Talecris Biotherapeutics
SK Plasma
CSL
Octapharma
Cerus

Related Reports

Global Specialty Control Plasma Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Specialty Control Plasma Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022